Polish researchers in leukemia breakthrough
PR dla Zagranicy
Polish scientists have discovered the cellular mechanism that drives the early development of chronic myelogenous leukemia (CML), also known as chronic granulocytic leukemia (CGL).
Malfunction in the synthesis of the BRCA1 protein is key to the early stages of the disease, a publication in the Cell Cycle research journal says.
The discovery will help with prognosis for patients with CML and may lead to the development of new treatment targeting BRCA1 deficiency.
Researchers at the M. Nencki Experimental Biology Institute of the Polish Academy of Science are responsible for the discovery.
CML is most commonly found in people in their 30s. (an)